Abstract
Carcinoma of the larynx accounts for 25–30 % of all carcinomas of the head and neck [1]. Early carcinomas of the larynx (Cis, T1, T2) and severe dysplasia are presently treated with either radiation therapy or surgery alone. Five-year cure rates achieved with this therapy is 75–90 %. Radiation therapy has the advantage of preserving the physical integrity of the larynx, thereby preserving the voice. Radiation therapy, however, has significant disadvantages even when small laryngeal fields of radiation are used. These disadvantages include discomfort and mucositis during and for potential prolonged periods after therapy, permanently altered voice quality, dysphagia, chondroradionecrosis of the larynx and trachea, and the extensive length of therapy (6–7 weeks) [2, 3]. Surgical therapy for early carcinomas, that is, T1 and T2, of the larynx includes performing a partial cordectomy or hemilaryngectomy. Although cure rates are high, surgical removal of portions of the vocal cord or hemilarynx results in significant alteration of the quality of voice [4].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Shah JP, Karnell LH, Hoffman HT, et al. Patterns of care for cancer of the larynx in the United States. Arch Otolaryngol Head Neck Surg. 1997;123:475–83.
VonEssen CF. Larynx and pyriform sinus. In: Fletcher GH, editor. Textbook of radiotherapy. Philadelphia: Lea & Febiger; 1982. p. 330–64.
Morris MR, Canonico D, Blank C. A critical review of radiotherapy in the management of T1 glottic carcinoma. Am J Otolaryngol. 1994;15(4):276–80.
Bailey BJ, Biller HF. Glottic carcinomas. In: Biller BJ, editor. Surgery of the Larynx. Philadelphia: W. B. Saunders; 1985. p. 257–77.
Le Q, Takamiya R, Shu H, et al. Treatment results of carcinoma in situ of the glottis. Arch Otolaryngol Head Neck Surg. 2000;126:1305–12.
Zeitels SM. Phonomicrosurgical treatment of early glottic cancer and carcinoma in situ. Am J Surg. 1996;172:704–9.
Smith JC, Johnson JT, Myers EN. Management and outcome of early glottic carcinoma. Otolaryngol Head Neck Surg. 2002;126(4):356–64.
Sittel C, Eckel H, Eschenburg C. Phonatory results after laser surgery for glottic carcinoma. Otolaryngol Head Neck Surg. 1998;119(4):418–24.
Chone CT, Yonehara E, Martins JEF, Altemani A, Crespo AN. Importance of anterior commissure in recurrence of early glottic cancer after laser endoscopic resection. Arch Otolaryngol Head Neck Surg. 2007;133(9):882–7.
Rucci L, Romagnoli P, Scala J. CO2 laser therapy in Tis and T1 glottic cancer: indications and results. Head Neck. 2010;32:392–8.
Garcia-Serra A, Hinerman RW, Amdur RJ, Morris CG, Mendenhall WM. Radiotherapy for carcinoma in situ of the true vocal cords. Head Neck. 2002;24:390–4.
Damm M, Sittel C, Streppel M, Eckel HE. Transoral CO2 laser surgical management of glottic carcinoma in situ. Laryngoscope. 2002;110:1215–21.
Khan MK, Koyfman SA, Hunter GK, Reddy CA, Saxton JP. Definitive radiotherapy for early (T1-2) glottic squamous cell carcinoma: a 20 year Cleveland clinic experience. Radiat Oncol. 2012;7:193.
Hafidh M, Tibbo J, Trites J, Corsten G, Hart RD, Nasser J, Wilke D, Taylor SM. Radiotherapy for T1 and T2 laryngeal cancer: the Dalhousie University experience. J Otolaryngol Head Neck Surg. 2009;38(4):434–9.
Hartl DM, Ferlito A, Brasnu DR, Langendijk JA, Rinaldo A, Silver CE, Wolf GT. Evidence-based review of treatment options for patients with glottic cancer. Head Neck. 2011;33:1638–48.
Lee HS, Chun B, Kim SW, Kim ST, Oh JH, Hong JC, Lee KD. Transoral laser microsurgery for early glottic cancer as a one-stage single-modality therapy. Laryngoscope. 2013;123:2670–4.
Batella FN, Cueva MJC, Gonzalez BS, Pendas JLL, Gil G, Llames AL, Pantiga RA, Nieto CS. Voice quality after endoscopic laser surgery and radiotherapy for early glottis cancer: objective measurements emphasizing the Voice Handicap Index. Eur Arch Otorhinolaryngol. 2008;265:543–8.
Freche C, DeCorbiere S. Use of photodynamic therapy in the treatment of vocal cord carcinoma. J Photochem Photobiol B. 1990;6:291–6.
Feyh J, Goetz A, Muller W, et al. Photodynamic therapy in head and neck surgery. J Photochem Photobiol B. 1990;7:353–8.
Gluckman JL. Hematoporphyrin photodynamic therapy: is there truly a future in head and neck oncology? Reflections on a 5-year experience. Laryngoscope. 1991;101:36–42.
Schweitzer V. Photofrin-mediated photodynamic therapy for treatment of early stage oral cavity and laryngeal malignancies. Lasers Surg Med. 2001;29(4):305–13.
Biel MA. Photodynamic therapy and the treatment of head and neck neoplasia. Laryngoscope. 1998;108:1259–68.
Biel MA. Advances in photodynamic therapy for the treatment of head and neck cancer. Lasers Surg Med. 2006;38:349–55.
Rigual NR, Thankappan K, Cooper M, Sullivan MA, Dougherty T, Popat SR, Loree TR, Biel MA, Henderson B. Photodynamic therapy for head and neck dysplasia and cancer. Arch Otolaryngol Head Neck Surg. 2009;135(8):784–8.
Dilkes MG, DeJode ML. m-THPC photodynamic therapy for head and neck cancer. Lasers Med Sci. 1996;11(1):23–9.
Grossman C, Zhu T, Finlay J, Dimofte A, Malloy K, O’Malley BO, Weinstein G, Busch TM, Quon H. Targeted laryngeal photodynamic therapy with a balloon diffusing light source. Photodiagn Photodyn Ther. 2010;7:158–61.
Abramson AL, Shikowitz MJ, Mullooly VM, Steinberg BM, Hyman RB. Variable light-dose effect on photodynamic therapy for laryngeal papillomas. Arch Otolaryngol Head Neck Surg. 1994;120(8):852–5.
Shikowitz MJ, Abramson AL, Steinberg BM, DeVoti J, Bonagura VR, Mullooly V, Nouri M, Ronn AM, Inglis A, McClay J, Freeman K. Clinical trial of photodynamic therapy with meso-tetra (hydroxyphenyl) chlorin for respiratory papillomas. Arch Otolaryngol Head Neck Surg. 2005;131(2):99–105.
Silbergleit AK, Somers ML, Schweitzer VG, Gardner GM, Peterson E. Vocal fold vibration after photofrin-mediated photodynamic therapy for treatment of early-stage laryngeal malignancies. J Voice. 2013;27(6):762–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this chapter
Cite this chapter
Biel, M.A. (2016). Photodynamic Therapy for the Management of Laryngeal Malignancies. In: Wong, BF., Ilgner, J. (eds) Biomedical Optics in Otorhinolaryngology. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1758-7_23
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1758-7_23
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1757-0
Online ISBN: 978-1-4939-1758-7
eBook Packages: MedicineMedicine (R0)